These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

203 related items for PubMed ID: 4849639

  • 21. Our experience with Moditene-Depot in chronic schizophrenia.
    Gamkrelidze ShA, Putkoradze-Gamkrelidze NA.
    Act Nerv Super (Praha); 1973 Aug; 15(3):169. PubMed ID: 4769133
    [No Abstract] [Full Text] [Related]

  • 22. Therapy with injectable fluphenazines.
    Ayd FJ.
    Curr Psychiatr Ther; 1976 Aug; 16():177-89. PubMed ID: 991628
    [No Abstract] [Full Text] [Related]

  • 23. The depot compounds moditen (fluphenazine) and IMAP (fluspirilene) in clinical practice.
    Faltus F.
    Act Nerv Super (Praha); 1974 Aug; 16(3):167-8. PubMed ID: 4607824
    [No Abstract] [Full Text] [Related]

  • 24. Observations on the use of long-acting depot neuroleptic injections in the maintenance therapy of schizophrenia.
    Johnson DA.
    J Clin Psychiatry; 1984 May; 45(5 Pt 2):13-21. PubMed ID: 6143743
    [Abstract] [Full Text] [Related]

  • 25. [Outcome in 64 chronic psychotics treated with delayed action Moditen or Modecate].
    Bastie Y.
    Ann Med Psychol (Paris); 1974 Apr; 1(4):531-6. PubMed ID: 4605833
    [No Abstract] [Full Text] [Related]

  • 26. Combined intramuscular administration of depot fluphenazine and benztropinemesylate in chronic schizophrenic patients.
    Bucci L.
    Curr Ther Res Clin Exp; 1971 Aug; 13(8):545-8. PubMed ID: 4999204
    [No Abstract] [Full Text] [Related]

  • 27. [Clinical study on five depot neuroleptics. Comparison of effective profiles of fluphenazinedecanoate, fluspirilene, penfluridol, perphenazine-enanthate and pipothiazinepalmitate].
    Angst J, Woggon B.
    Arzneimittelforschung; 1975 Feb; 25(2):267-70. PubMed ID: 1091272
    [Abstract] [Full Text] [Related]

  • 28. The use of depot neuroleptics: clinical experience in the United States.
    Kane JM.
    J Clin Psychiatry; 1984 May; 45(5 Pt 2):5-12. PubMed ID: 6370987
    [Abstract] [Full Text] [Related]

  • 29. Haloperidol decanoate as a replacement for maintenance therapy with intramuscular fluphenazine decanoate in schizophrenia and other chronic psychoses.
    Roose K.
    Acta Psychiatr Belg; 1982 May; 82(2):216-23. PubMed ID: 7180558
    [Abstract] [Full Text] [Related]

  • 30. The contribution of fluphenazine enanthate and decanoate in the prevention of readmission of schizophrenic patients.
    Denham J, Adamson L.
    Acta Psychiatr Scand; 1971 May; 47(4):420-30. PubMed ID: 4336483
    [No Abstract] [Full Text] [Related]

  • 31. Double-blind placebo substitution: withdrawal of fluphenazine decanoate in schizophrenic patients.
    Odejide OA, Aderounmu AF.
    J Clin Psychiatry; 1982 May; 43(5):195-6. PubMed ID: 7076630
    [Abstract] [Full Text] [Related]

  • 32. [The position of the depot-neuroleptics in the therapy of chronic psychoses. Experience with fluphenazine-decanoate].
    Auch W.
    Med Welt; 1970 Oct 10; 21(41):1785-8. PubMed ID: 5471981
    [No Abstract] [Full Text] [Related]

  • 33. Maintenance therapy and schizophrenia.
    Leff JP.
    Br J Psychiatry; 1975 Oct 10; Spec No 9():55-8. PubMed ID: 241453
    [No Abstract] [Full Text] [Related]

  • 34. Fluphenazine enanthate in the outpatient treatment of late paraphrenia.
    Raskind M, Alvarez C, Herlin S.
    J Am Geriatr Soc; 1979 Oct 10; 27(10):459-63. PubMed ID: 469146
    [Abstract] [Full Text] [Related]

  • 35. Plasma levels of parent drug and metabolites in patients receiving oral and depot fluphenazine.
    Marder SR, Van Putten T, Aravagiri M, Hubbard JW, Hawes EM, McKay G, Midha KK.
    Psychopharmacol Bull; 1989 Oct 10; 25(3):479-82. PubMed ID: 2626520
    [Abstract] [Full Text] [Related]

  • 36. [Comparative investigation of action and side effects in intravenous, intramuscular and oral application of fluphenazine dihydrochloride (author's transl)].
    Maurer YA.
    Pharmakopsychiatr Neuropsychopharmakol; 1979 Sep 10; 12(5):366-74. PubMed ID: 504343
    [Abstract] [Full Text] [Related]

  • 37. Controlled trial of depot fluphenazine in out-patient schizophrenics.
    Crawford R, Forrest A.
    Br J Psychiatry; 1974 Apr 10; 124(0):385-91. PubMed ID: 4599422
    [No Abstract] [Full Text] [Related]

  • 38. [Trial of a delayed-action neuroleptic, fluphenazine oenanthate (Moditen-retard, Squibb Lab.)].
    Haumonté MT, Hoerdt HP.
    Ann Med Psychol (Paris); 1972 Feb 10; 1(2):277-83. PubMed ID: 5051257
    [No Abstract] [Full Text] [Related]

  • 39. [Characteristics of the psychotropic activity of long-acting drugs (experience in the use of Moditen-depot)].
    Smulevich AB, Minsker EI, Mazaeva NA, Volkova RP, Lukanina SK.
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1972 Feb 10; 72(6):912-20. PubMed ID: 5050051
    [No Abstract] [Full Text] [Related]

  • 40. Dose response of prophylactic antipsychotics.
    Davis JM, Kane JM, Marder SR, Brauzer B, Gierl B, Schooler N, Casey DE, Hassan M.
    J Clin Psychiatry; 1993 Mar 10; 54 Suppl():24-30. PubMed ID: 8097195
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.